Potential noncontraceptive benefits of cyclic estrogen-progestin contraceptives

• Reduction in dysmenorrhea

• Reduction in pelvic pain related to endometriosis

• Reduction of menorrhagia, with improvement in iron deficiency anemia related to blood loss

• Reduction in risk of ectopic pregnancy

• Reduction in symptoms associated with premenstrual syndrome and premenstrual dysphoric disorder

• Reduction in risk of benign breast disease

• Reduction in development of new ovarian cysts (true for higher dose estrogen pills only, which suppress ovulation), but no effect on existing ovarian cysts

• Reduction in ovarian cancer, including some hereditary forms, such as those associated with mutations in the BRCA1 or BRCA2 gene, presumably due to inhibition of ovarian stimulation

• Reduction in endometrial cancer, due to the progestin effect

• Reduction in colorectal cancer in current users

• Reduction in moderate acne

• Reduction in hirsutism

• More regular menstrual cycles

In addition, there may be a reduction in postmenopausal hip fracture risk for women who use estrogen-containing contraceptives in their 40s. Also, extended cycle or continuous estrogen-progestin contraception can reduce symptoms of menstrual migraine.

Graphic 82147 Version 3.0

خرید پکیج

Potential noncontraceptive benefits of cyclic estrogen-progestin contraceptives